Updated Recommendations for use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
!

retired


This Document Has Been Retired.
Updated Recommendations for use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months
  • Published Date:

    June 26, 2009

  • Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(24):673-4.
  • Language:
    English
Filetype[HTM]


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Personal Author:
    Briere, Elizabeth C.
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Meningitis and Vaccine Preventable Diseases Branch.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2013 February 20-21 : Atlanta, GA)
    Published Date:
    February 20, 2013
    Series:
    ACIP meeting Meningococcal and Haemophilus influenzae Type B Vaccines
    Description:
    02-Hib-Briere.pdf
    File Type:
    Filetype[PDF - 347.49 KB]
    File Type:
    Filetype[PDF - 347.49 KB]
  2. Personal Author:
    Kroger, Andrew T.
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division.
    Published Date:
    August 21, 2019
    Series:
    Pink book webinar series
    Epidemiology and prevention of vaccine preventable diseases webinar series
    Description:
    This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for provider...
    File Type:
    Filetype[PDF - 4.90 MB]
    File Type:
    Filetype[PDF - 4.90 MB]
  3. Personal Author:
    Rubin, Lorry
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Meningococcal and Haemophilius influenzae Type B Vaccine Work Group. ; National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. ;
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2013 February 20-21 : Atlanta, GA)
    Published Date:
    February 20, 2013
    Series:
    ACIP meeting Meningococcal and Haemophilus influenzae Type B Vaccines
    Description:
    01-Intro-Rubin.pdf
    File Type:
    Filetype[PDF - 276.44 KB]
    File Type:
    Filetype[PDF - 276.44 KB]
  4. Published Date:
    September 18, 2009
    Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(36):1008-9.
    Description:
    On August 19, 2009, the Food and Drug Administration (FDA) licensed Hiberix (GlaxoSmithKline Biologicals, Rixensart, Belgium), a Haemophilus influenza...
    Status:
    current
    File Type:
    Filetype[HTM]
    File Type:
    Filetype[HTM]
  5. Personal Author:
    Briere, Elizabeth C. ; Jackson, Michael ; ...
    Published Date:
    Aug 06 2012
    Source:
    Pediatrics. 130(3):414-420.
    Description:
    BACKGROUNDSince the introduction of effective vaccines, the incidence of invasive Haemophilus influenzae type b (Hib) disease among children <5 years ...
    File Type:
    Filetype[PDF - 319.97 KB]
    File Type:
    Filetype[PDF - 319.97 KB]